IGF1R and cancer: Accumulating evidence indicates that a variety of tumor systems including colorectal cancers express high levels of insulin-like growth factor-I receptor (IGFIR) [2,3], which initiates intracellular signaling cascades that enhance cell cycle progression and inhibit apoptosis [4], finally led to prosperity of cancer cells and increased tumor invasion [5,6].